Evidence map›Paper›PMID 42531073›Full record

ArticleNucleic acids research2026

A multivalent RNA affinity tag enables selective purification of tagged RNAs and bound proteins.

Ki Sung Park, Sourav Kumar Dey, Rohit Nalavade, Aashiq H Mirza, Qian Hou, Mateo A Martinez Roque, Maxim Oleynikov, Jacob L Litke, Samie R Jaffrey

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ki Sung ParkDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.ORCID 0000-0003-2636-1675
Sourav Kumar DeyDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.
Rohit NalavadeDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.ORCID 0000-0002-9040-8485
Aashiq H MirzaDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.ORCID 0000-0002-9655-5267
Qian HouDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.
Mateo A Martinez RoqueDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.
Maxim OleynikovDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.
Jacob L LitkeDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.ORCID 0000-0002-2600-6131
Samie R JaffreyDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, United States.ORCID 0000-0003-3615-6958

Funding

Center for Multi-Scale Analysis of the Human EpitranscriptomeRM1HG011563 · NHGRI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAMIE R JAFFREY, Kathryn D Meyer · 2021 to 2026
$22.2M
New mechanisms and technologies for understanding post-transcriptional gene regulation in neuronsR35NS111631 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAMIE R JAFFREY · 2019 to 2026
$8.6M
Ultra-sensitive multi-mode laser-scanning imaging systemS10OD030335 · OD · WEILL MEDICAL COLL OF CORNELL UNIV · PI JAFFREY, SAMIE R · 2021 to 2021
$163k
NHGRI NIH HHS RM1 HG011563NIH HHS R35NS111631NIH HHS RM1 HG011563NIH HHS S10 OD030335NINDS NIH HHS R35 NS111631
6 · The paper itself

Abstract

Efficient purification of specific RNAs from lysates remains a major challenge. Existing methods, such as MS2 tagging or oligonucleotide hybridization, require protein immobilization or sequence-specific hybridization, limiting scalability and compatibility with diverse RNAs. Current approaches often have low recovery, exhibit slow kinetics, and generate background contamination, limiting their use in RNA-protein interaction studies. To overcome these limitations, we developed FS2, an RNA sequence that binds Sephadex beads with high affinity, thus acting as an affinity tag for protein-free, rapid, and simple RNA purification. FS2 consists of two copies of the dextran-binding D8 aptamer embedded within the highly stable F30 three-way junction RNA scaffold, which promotes aptamer folding and enhances avidity. Systematic optimization revealed that FS2 exhibits rapid binding kinetics, efficient purification, and efficient elution under mild conditions (50°C, 10 mM EDTA), representing substantial improvements over existing RNA purification systems. We validated the utility of FS2 by purifying an FS2-tagged MYC mRNA fragment from HEK293T cells and demonstrating that N6-methyladenosine (m6A)-containing mRNAs can be pulled down along with the m6A-binding protein YTHDF2. Overall, FS2 provides a highly simple and efficient RNA-based affinity tag for recovering RNA from complex mixtures and lysates for diverse applications.

Indexed as

Aptamers, NucleotideRNARNA-Binding ProteinsRNA, MessengerChromatography, AffinityHEK293 CellsHumansKineticsProtein BindingProto-Oncogene Proteins c-mycRNA MethylationAptamers, NucleotideProto-Oncogene Proteins c-mycRNARNA-Binding ProteinsRNA, Messenger

Identifiers

PMID42531073
PMCPMC13421773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.